USTEKINUMAB-TTWE

191 reported adverse events

Drug classes: Interleukin-12 Antagonist [EPC] Interleukin-23 Antagonist [EPC]

These side effects are most commonly reported by patients taking USTEKINUMAB-TTWE:

# Side effect Count
0 CROHN^S DISEASE 27
1 DRUG INEFFECTIVE 20
2 PRODUCT SUBSTITUTION ISSUE 18
3 DIZZINESS 15
4 ABDOMINAL PAIN 14
5 INFECTION 14
6 CONDITION AGGRAVATED 13
7 DIARRHOEA 12
8 OFF LABEL USE 11
9 SYNCOPE 11
See all common reactions for USTEKINUMAB-TTWE

USTEKINUMAB-TTWE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ECTOPIC PREGNANCY 3 0.0010
1 CLOSTRIDIAL INFECTION 2 0.0006
2 HEPATIC CANCER STAGE IV 2 0.0005
3 GUILLAIN-BARRE SYNDROME 2 0.0004
4 INFLAMMATORY MARKER INCREASED 2 0.0004
5 MENSTRUAL DISORDER 3 0.0004
6 GASTRITIS 9 0.0003
7 MELAENA 7 0.0003
8 PRODUCT SUBSTITUTION ISSUE 18 0.0003
9 IMMUNOSUPPRESSION 2 0.0002
See all enriched reactions for USTEKINUMAB-TTWE